Company Analysis Xtant Medical Holdings, Inc.
1. Summary
Advantages
- Current debt level 24.49% is below 100% and has decreased over 5 years from 181.71%.
- The company's current efficiency (ROE=1.29%) is higher than the sector average (ROE=-80.86%)
Disadvantages
- Price (1.06 $) is higher than fair price (0.0691 $)
- Dividends (0%) are below the sector average (1.32%).
- The stock's return over the last year (-59.29%) is lower than the sector average (-31.87%).
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Xtant Medical Holdings, Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 27.8% | -2.2% | -1.5% |
| 90 days | -31.3% | -33.2% | 0.2% |
| 1 year | -59.3% | -31.9% | 18.4% |
XTNT vs Sector: Xtant Medical Holdings, Inc. has significantly underperformed the "Healthcare" sector by -27.43% over the past year.
XTNT vs Market: Xtant Medical Holdings, Inc. has significantly underperformed the market by -77.69% over the past year.
Stable price: XTNT is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: XTNT with weekly volatility of -1.14% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (1.06 $) is higher than the fair price (0.0691 $).
Price is higher than fair: The current price (1.06 $) is 93.5% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (234.38) is higher than that of the sector as a whole (114.5).
P/E vs Market: The company's P/E (234.38) is higher than that of the market as a whole (70.26).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (3.01) is lower than that of the sector as a whole (9.44).
P/BV vs Market: The company's P/BV (3.01) is lower than that of the market as a whole (22.61).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (1.69) is lower than that of the sector as a whole (4.13).
P/S vs Market: The company's P/S indicator (1.69) is lower than that of the market as a whole (15.24).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-24.67) is lower than that of the sector as a whole (17.79).
EV/Ebitda vs Market: The company's EV/Ebitda (-24.67) is lower than that of the market as a whole (24.37).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -21.89% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-21.89%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-57.12%).
5.4. ROE
ROE vs Sector: The company's ROE (1.29%) is higher than that of the sector as a whole (-80.86%).
ROE vs Market: The company's ROE (1.29%) is lower than that of the market as a whole (18.07%).
5.5. ROA
ROA vs Sector: The company's ROA (0.7127%) is lower than that of the sector as a whole (6.71%).
ROA vs Market: The company's ROA (0.7127%) is lower than that of the market as a whole (6.49%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.68%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (9.31%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.32%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
